Concepedia

D. Von Hoff

DV

11

Publications

1.9K

Citations

11

H-Index

1991

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Texas Oncology

D. Von Hoff is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1991–2014

11

Publications

11

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

Eric Van Cutsem, Helgi van de Velde, Petr Karásek et al. · Journal of Clinical Oncology · 2004 · 772 citations · Full text

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer

Helmut Oettle, Donald Richards, Rajesh Ramanathan et al. · Annals of Oncology · 2005 · 304 citations · Full text

, , +8

A phase I trial of taxol given by a 6-hour intravenous infusion.

T.D. Brown, Kathleen A. Havlin, Geoffrey R. Weiss et al. · Journal of Clinical Oncology · 1991 · 182 citations

, , +12

Phase I Evaluation of ISIS 3521, an Antisense Oligodeoxynucleotide to Protein Kinase C-Alpha, in Patients With Advanced Cancer

John Nemunaitis, Jon Holmlund, Maura A. Kraynak et al. · Journal of Clinical Oncology · 1999 · 172 citations

DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.

C. van den Berg, Xin‐Yuan Guan, D. Von Hoff et al. · PubMed · 1995 · 104 citations

, , +15

Rows per page

1–5 of 11